ETFChannel.com
First Trust Nasdaq Pharmaceuticals ETF

Fund Name:
First Trust Nasdaq Pharmaceuticals ETF
Issuer:
First Trust
Total Net Assets:
$19,693,008
Inception:
9/20/2016
Related Index:
ETF Category: 
Health
Expense Ratio: 
0.60% 
Net Asset Value: 
$26.26  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
FTXH.NV  
Number of Holdings: 
50  
Annualized Yield: 
1.47%  
Annualized Distribution: 
0.385  
FTXH Dividend History » 
Stock Weight Amount
Pfizer 7.43% $1,463,747
Merck & CO., 7.41% $1,459,095
Bristol-myers Squibb Company 7.19% $1,416,130
Abbvie 7.12% $1,402,143
Johnson & Johnson 6.87% $1,353,706
List of all 52 stocks held by FTXH »
Quotes delayed 20 minutes

Email EnvelopeFree FTXH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.13 out of 4)
6th percentile
(ranked lower than approx. 94% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
RDVY   $10,214,561,956
FVD   $9,749,323,070
FTCS   $8,680,692,756
FTSM   $6,528,290,509
CIBR   $6,389,476,248
List of all 162 others »

FTXH | First Trust Nasdaq Pharmaceuticals ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.